(Q43148840)

14 November 2017

0 references

Bevacizumab--news from the fast lane? (English)

1 reference

14 November 2017

1 reference

1

Michael Weller

1 reference

14 November 2017

W K Alfred Yung

2

1 reference

14 November 2017

5 September 2008

1 reference

14 November 2017

1 reference

14 November 2017

10

1 reference

14 November 2017

5

1 reference

14 November 2017

647

1 reference

High-grade glioma before and after treatment with radiation and Avastin: initial observations

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666241

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666241

Bevacizumab plus irinotecan in recurrent glioblastoma

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666241

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666241

10.1215/15228517-2008-074

15 August 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference

PMC publication ID

2666241

14 November 2017

PubMed publication ID

18776128

1 reference

PMC publication ID

2666241